International Summit on Hematology and Blood Disorders

April 27-29, 2023

April 27 -29, 2023 | Online Event

Hematology 2023

Donald R Branch, Speaker at Hematology Conferences
Keynote Presentation
Donald R Branch, University of Toronto, Canada

Background: Hemolysis is a potentially life-threatening state owing to congenital or acquired conditions.  Mechanisms of erythrocyte-destruction can be intrinsic or extrinsic, with the latter being non-immune or immune. In the current dogma of immune hemolysis as an exclusiv [....] » Read More

Jie Xu, Speaker at Hematology Conferences
Keynote Presentation
Jie Xu, The University of Texas MD Anderson Cancer Center, United States

The programmed cell death 1 (PD-1) pathway is a recently recognized mechanism of tumor immune evasion.  In our study, programmed cell death ligand 1 (PD-L1) expression was evaluated in patients with systemic anaplastic large cell lymphoma: including ALK+ and ALK-negative cas [....] » Read More

Thad Cummings, Speaker at Hematology Conferences
Oral Presentation
Thad Cummings, Thad Cummings, United States

Workshop/Speech Dynamics: The focal point of this workshop is using the latest social psychology research to breakdown what is causing the emotional and physical stress in the workplace and the stigmas that society has implemented in reaction to it. There will be hands on discus [....] » Read More

Pranavi Sanka, Speaker at Hematology Conferences
Oral Presentation
Pranavi Sanka, Brown University, United States

Background: Antiphospholipid syndrome (APLS) is a hypercoagulable state characterized by thrombotic events (venous or arterial) or obstetric complications along with persistent positivity of antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, or β2-glycoprotei [....] » Read More

Priyal Shah, Speaker at Blood Disorders Events
Oral Presentation
Priyal Shah, University of Toronto, Canada

COVID-19, caused by SARS-CoV-2, requires the coronavirus Spike (S)-protein, host receptor ACE2 and the protein TMPRSS2 for infection. Emerging progeny viruses use host plasma membrane, which may or may not contain ABH(O) antigens, as part of their virus envelope. Multiple studi [....] » Read More

Melika Loriamini, Speaker at Hematology Conferences
Oral Presentation
Melika Loriamini, University of Toronto, Canada

Immune cytopenias are characterised by low numbers of certain hematopoietic cells and include immune thrombocytopenia (ITP), autoimmune hemolytic anaemia (AIHA), hemolytic transfusion reactions (HTR), hemolytic disease of the fetus and newborn (HDFN), and autoimmune neutropenia [....] » Read More

Milos Bohonek, Speaker at Hematology Conferences
Oral Presentation
Milos Bohonek, Military University Hospital Prague, Czech Republic

The short shelf-life of fresh platelets (PLTs) limits their efficient inventory management and availability during a massive transfusion protocol. Risk of insufficient availability can be mitigated by building an inventory of cryopreserved platelets. Method: Platelets are froz [....] » Read More

Shaik Mahmood, Speaker at Blood Disorders Events
Oral Presentation
Shaik Mahmood, Deccan College of Medical Sciences, India

Diabetes Mellitus (DM) is a common metabolic disorder cause high sugar levels(more than 300mg/dl) in the blood for a long period. If it is left untreated to a long period it can lead to long term complications, such as cardiovascular disorders, stroke, and diabetic retinopathy or [....] » Read More

Serwaa Akoto Bawua, Speaker at Blood Disorders Conference
Oral Presentation
Serwaa Akoto Bawua, University of Ghana, Ghana

Background: Haematological reference intervals (RIs) are known to be influenced by race and/or geographical factors. In Ghana, most diagnostic laboratories still rely on RIs provided by the manufacturer of haematology analyzers. This study was therefore conducted to establish hae [....] » Read More

Amar, Speaker at #HematologyConferences
Oral Presentation
Amar, University of Garden City, Sudan

Hereditary hemolytic anemias are rare; however, when a baby is born with the condition, acute episodes manifest themselves during the first months and years of childhood. The main objective of this study is to describe the use of a simple method, namely, the thermal stress test, [....] » Read More

Young Tom, Speaker at Hematology Conferences
Oral Presentation
Young Tom, Cross River State Ministry of Health, Nigeria

Hematology is the study of blood and blood disorders. Hematologist and hematopathologist are highly trained health care providers who specialize in disease of the blood and blood components. These include blood and bone marrow cells. Sickle Cell Disease (SCD) is a genetic diseas [....] » Read More

Emmanuel Ikubese, Speaker at Hematology Conferences
Oral Presentation
Title : MZIGO Project
Emmanuel Ikubese, Advocate, Nigeria

Sickle Cell Disease is one of the world’s most common genetic diseases, affecting an increasing number of people but is still relatively unknown to the wider public. It poses a significant public health problem notably in sub-Saharan Africa. The greatest burden of SCD is in [....] » Read More

Evelyn Harlow Mwesigwa, Speaker at Hematology Conferences
Oral Presentation
Evelyn Harlow Mwesigwa, Uganda National Health Laboratory and Diagnostic Services Ministry of Health, Uganda

In Uganda, a plethora of a health priorities heavily weighted by infectious/communicable diseases which take precedence in resource allocation have left non-communicable diseases such as sickle cell anaemia largely under-studied. The sickle cell trait burden in the country was re [....] » Read More

Zineb Boukhal Zerouali, Speaker at Hematology Conferences
Oral Presentation
Zineb Boukhal Zerouali, Ibn Rochd University Hospital Center, Morocco

Introduction: The giant aneurysm of the subclinoid portion of the internal carotid artery is a relatively rare disease which can present serious complications. Patient and methods: We report the case of a 40-year-old man complaining of headache with complete ophthalmoplegia of [....] » Read More

Hamzullah Khan, Speaker at Blood Disorders Conference
Oral Presentation
Hamzullah Khan, Nowshera Medical College, Pakistan

Objectives: to determine the predictive values of peripheral hematological markers for remission in cases of Plasma cell disorders/Multiple myeloma after induction therapy. Material and methods:This prospective study was conducted in the department of Hematology, MTI Hayatabad [....] » Read More

Naveed Akhtar, Speaker at Hematology Meetings
Oral Presentation
Naveed Akhtar, Hazara University, Pakistan

Thalassaemia is a life-threatening rare disease, which requires regular blood transfusion and medical care. In this study we investigate the impact of COVID-19 pandemic on the transfusion dependent thalassemia patients in district Battagram. It was found that during the corona pa [....] » Read More

Zahra Kashani Khatib, Speaker at Hematology Conferences
Oral Presentation
Zahra Kashani Khatib, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Introduction: New and old chemotherapy drugs, stem cell transplantation and many other methods are trying to minimize the challenges in the treatment of acute myeloid leukemia (AML). One of the newest of these methods is immunotherapy by nanovesicles called exosome. The bene [....] » Read More

Naser Shagerdi Esmaeli, Speaker at Hematology Conferences
Oral Presentation
Naser Shagerdi Esmaeli, Shahid Beheshti University of Medical Science, Iran (Islamic Republic of)

Background: Oral anticoagulant therapy is used to prevent thrombosis in patients with atrial fibrillation (AF), venous thrombosis and prosthetic heart valves. The introduction of new therapies emphasizes the need to discern the best practice for the patients remaining on warfarin [....] » Read More

Aristotle G Koutsiaris, Speaker at Hematology Conferences
Oral Presentation
Aristotle G Koutsiaris, University of Thessaly, Greece

Currently, more than 6.8 million deaths have been reported globally [WHO] from the COVID-19 pandemic and numerous symptoms have been observed in patients surviving COVID-19 which were described by the term “long COVID syndrome”. The injured endothelium has a primary r [....] » Read More

Merve Pamukcuoglu, Speaker at Hematology Conferences
Oral Presentation
Merve Pamukcuoglu, Bilkent City Hospital of Ankara, Turkey

Hepatic veno-occlusive disease (VOD) / sinusoidal obstruction syndrome (SOS) is a mortal disease being seen in Hematopoietic Stem Cell Transplantation (HSCT). It was seen in almost 14% of all HSCT cases (adult and pediatric) and 30% in pediatric patients. Whereas anicteric VOD wa [....] » Read More

Erin Weigel, Speaker at Hematology Conferences
Poster Presentation
Erin Weigel, Kedrion Biopharma, United States

Plasminogen deficiency (PLGD) is an ultra-rare disorder, which is a subset of rare diseases that affect less than 1,000 individuals in a country. PLGD is classified as hypoplasminogenemia (PLGD-1) or dysplasminogenemia (PLGD-2). PLGD-2 is typically an asymptomatic qualitative dis [....] » Read More

Katie Lovell, Speaker at #HematologyConferences
Poster Presentation
Katie Lovell, Brody School of Medicine, United States

Acquired Factor VIII inhibitors are a rare cause of often extensive bleeding and subsequently large hematomas. Acquired hemophilia A (AHA) often presents in patients with no personal or familial history of bleeding.  AHA risk factors are associated with autoimmune disea [....] » Read More

 Shima Azadpour, Speaker at #HematologyConferences
Poster Presentation
Shima Azadpour, University of British Columbia, Canada

Background: Chronic graft- vs.-host disease (cGvHD) is a major long-term complication of hematopoietic stem cell transplantation (HSCT) resulting in high levels of morbidity and mortality post-HSCT. Despite recent progress, few biomarkers for prediction and early diagnosis o [....] » Read More

Edina Toman, Speaker at Blood Disorders Conference
Poster Presentation
Edina Toman, ELTE Eotvos Lorand University, Hungary

The central topics of our research are living with thrombophilia disease, its impact on the identity and life of the persons as well as attributing meaning to the disease. We also consider the appearance of transgenerational aspects in the lives of thrombophilia patients to be pa [....] » Read More

Asif Mahmood, Speaker at Blood Disorders Conference
Poster Presentation
Asif Mahmood, Jiangsu University, China

Hepatitis is the inflammation, irritation or swelling of liver cells, caused by many biotic and abiotic factors. Hepatitis caused by Hepatitis C virus (HCV) is one of the most common bloodborne viral infections in the world and a leading cause of deaths infecting about 2.5 to 3% [....] » Read More

Urmila, Speaker at #HematologyConferences
Poster Presentation
Urmila, Postgraduate Institute of Medical Education and Research, India

Background & aim: Thalassemia syndromes are a group of hereditary hematological disorders that affects a significant proportion of children, contributing to childhood morbidity and mortality. Parents play a key role in the long term management and treatment of thalassemic chi [....] » Read More

Pamela Christa B Tongco, Speaker at Blood Disorders Conferences
Poster Presentation
Pamela Christa B Tongco, Our Lady of Lourdes Hospital, Philippines

This describes a case of Chronic Myelogenous Leukemia (CML) with transformation to T-cell Lymphoid Blast Crisis, its presentation, course, and treatment. As this is a very uncommon occurrence, it is imperative to fully investigate and diagnose this condition to fully optimize pot [....] » Read More

 Saleh Abohadi, Speaker at Hematology Conferences
Poster Presentation
Saleh Abohadi, National Oncology Center, Yemen

Background: Precise classification of acute leukemia is crucial for adequate treatment. Objectives: This study carried out to determine the ability to delineate cell lineage of acute leukemias using 3-colored flow cytometry in a war-torn resource constrained country. Methods: I [....] » Read More

Joyce Duku, Speaker at Hematology Conferences
Poster Presentation
Joyce Duku, Ghana Health Service, Ghana

Background: Caring for children with sickle cell disease (SCD) is quite demanding and poses extra constraints on caregivers. In Africa, SCD is an all-round financial, physical and emotional stressor for caregivers of sufferers. The work aims at exploring and describing the exper [....] » Read More

Epifania Rita Testa, Speaker at Hematology Conferences
Poster Presentation
Epifania Rita Testa, S Maria Degli Angeli Hospital, Italy

Patients affected from high affinity for oxygen hemoglobinopathies with congenital erythrocytosis require phlebotomy therapy. These patients have complex diagnostic classification of polyglobulia that is often delayed by a series of haematological, cardiological, nephrological, p [....] » Read More

Ebtihal Ahmed Babekir Omer, Speaker at Hematology Conferences
Poster Presentation
Ebtihal Ahmed Babekir Omer, Al Neelain University, Sudan

Background: Serum iron levels vary throughout the day, morning samples were assumed to be higher than afternoon or evening levels. This descriptive observational case study was conducted during June to August 2013 in Khartoum state to determine the diurnal variation of serum iron [....] » Read More

Stefan Gluck, Speaker at Blood Disorders Conference
Keynote Presentation
Stefan Gluck, Global Medical Affairs at Celgene Corporation, United States

The idea of using the immune system to fight cancer is over 100 years old. (Paul Ehrlich’s “Magic Bullet”). A new molecular approach over the last decade or so, led to a better understanding of the immune system. Our focus became the T cell, its development and [....] » Read More

A C Matin, Speaker at Hematology Conferences
Keynote Presentation
A C Matin, Stanford Medical School, United States

Bacteria like Escherichia coli cause disease but are also useful in resource regeneration. Its UPEC strain causes cystitis, which is treated by gentamicin. The protein Ys, encoded by the rpoS gene, controls E. coli resistance to antimicrobial agents. We discovered that rpoS delet [....] » Read More

Joan LLuis Vives Corrons, Speaker at Hematology Conferences
Keynote Presentation
Joan LLuis Vives Corrons, University of Barcelona, Spain

Hereditary red blood cell (RBC) membranopathies are characterized by mutations in genes encoding skeletal/lipid bilayer proteins that alter the membrane complex structure. Hereditary spherocytosis (HS) is the most common inherited RBC membranopathy, leading to hereditary hemolyti [....] » Read More

Ahmed N Ghanem, Speaker at Hematology Conferences
Keynote Presentation
Ahmed N Ghanem, Mansoura University, Egypt

Introduction and objective: To report the hydrodynamic of a porous orifice (G) tube as replacement for the wrong Starling’s law. Material and methods: Hydrodynamics of the G tube, based on capillary ultra-structure, were studied. The effect of changing G tube o [....] » Read More

Michiko N Fukuda, Speaker at Hematology Conferences
Oral Presentation
Michiko N Fukuda, Sanford Buhnham Prebys Medical Discovery Institute, United States

Annexin A1 is expressed specifically on the tumour vasculature surface. Intravenously injected IF7 peptide (IFLLWQR) targets tumour vasculature via annexin A1. We tested the hypothesis that IF7 overcomes the blood–brain barrier and that the intravenously injected IF7C(RR)-S [....] » Read More

Alex Joseph Chandy, Speaker at Hematology Conferences
Oral Presentation
Alex Joseph Chandy, Doctor, United Kingdom

Deep vein thrombosis (DVT) is a major preventable cause of morbidity and mortality. While early recognition of the condition is important, equally important is the identification of possible etiological factors. Each patient with venous thrombosis would have multiple factors resp [....] » Read More

Francis Ajeneye, Speaker at Hematology Conferences
Oral Presentation
Francis Ajeneye, Princess Alexandra Hospital NHS Trust, United Kingdom

The National blood transfusion center gives its utmost priority to safe blood transfusion and this is done through monitoring all the threats that can be transmitted through blood transfusion. Safe blood transfusion depends on efficient testing techniques for blood donors and an [....] » Read More

Francis Ajeneye, Speaker at Hematology Conferences
Oral Presentation
Francis Ajeneye, Princess Alexandra Hospital NHS Trust, United Kingdom

Trauma remains a leading cause of death in all ages. Haemorrhagic shock accounts for 80% of deaths in the operating theatre and up to 50% of deaths in the first 24 h after injury. Exsanguination is an important cause of mortality for trauma patients, and the successful management [....] » Read More

Jean Mercier Ythier, Speaker at Hematology Meetings
Oral Presentation
Jean Mercier Ythier, University of Paris-Pantheon-Assas, France

Voluntary, anonymous free gift-giving has become nowadays the dominant norm for blood donation for transfusion purposes, in view of its established ability to satisfy the needs in labile blood products in satisfactory conditions of safety and cost. But the economy of blood produc [....] » Read More

 Yongjian Yue, Speaker at Hematology Conferences
Oral Presentation
Yongjian Yue, The First Affiliated Hospital of Southern University of Science and Technology, China

Currently, there is without a standard consensus for the definition of all hematopoietic progenitor (HPCs) lineages. This is owing to the inconsistent classification with conflict functional outcomes among the current studies. Single cell sequencing approaches have enabled the op [....] » Read More

Xing Cui, Speaker at Hematology Conferences
Oral Presentation
Xing Cui, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, China

Multiple myeloma (MM) is still an incurable disease and osteoclast-mediated bone destruction is a hallmark. Existing agents effectively reduce the number of osteoclasts (OCs) and prevent bone-related diseases but have little effect on overall survival. Investigating the potential [....] » Read More

Reena Nair, Speaker at Hematology Meetings
Oral Presentation
Reena Nair, TATA Medical Centre, India

Despite a low incidence of lymphoma, mortality remains high in Low/Medium HDI countries [1, 2]. The possible reasons include – limited access to tertiary cancer or specialized centres, and lack of trained  pathologists [3]. Patients present with advanced stage dis [....] » Read More

Ritu Sharma, Speaker at Hematology Conferences
Oral Presentation
Ritu Sharma, Government Medical College, India

A procoagulant state and dysfunctional immune response prevails in SARS-Cov2 infection. The goal of the present study was to explore the trend of potential parameters such as D-Dimer, IL-6, C-reactive protein and Pro-calcitonin (PCT) in Covid-19 patients. The study was conducted [....] » Read More

D R Ingle, Speaker at Blood Disorders Events
Oral Presentation
D R Ingle, Bharati Vidyapeeth College of Engineering, India

In the current digital world, hash may consider as a footprint or fingerprint of any digital term but from ancient era human fingerprint considered as the most trustworthy criteria for identification. The fingerprint of a human cannot be change with time even up to death of an in [....] » Read More

Diwakar Sharma, Speaker at Hematology Conferences
Oral Presentation
Diwakar Sharma, All India Institute of Medical Sciences, India

Philadelphia (Ph) positive chromosome comprises 90-95% of chronic myeloid leukemia (CML). The remaining 5-10% consists of intricate translocations that may involve a third chromosome. The impact of Tyrosine kinase inhibitor (TKI) treatment on the variant Ph Chromosomes is not k [....] » Read More

Ashraful Hoque, Speaker at Blood Diseases Congress
Oral Presentation
Ashraful Hoque, Sheikh Hasina National Institute of Burn & Plastic Surgery, Bangladesh

A variety of sterilization techniques are used to clean medical equipment, including steam, dry heat, radiation, ethylene oxide gas, evaporated hydrogen peroxide, and other sterilization techniques (for example, chlorine dioxide gas, vaporized peracetic acid, and nitrogen dioxide [....] » Read More

Gilad Itchaki, Speaker at Hematology Conferences
Oral Presentation
Gilad Itchaki, Meir Hospital, Israel

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western World. Therapeutic options have changed dramatically over the last decade, from ineffective chemotherapy to highly specific small molecules that target crucial pathways in CLL cells. The first available [....] » Read More

Abdullah Ali Gafar, Speaker at Hematology Conferences
Oral Presentation
Abdullah Ali Gafar, Ministry of public Health-Yemen, Yemen

Background: Identifying and understanding the factor  that influence health-related quality of life (HRQOL) in patients with leukemia  is critical to creating more appropriate clinical, counseling, and social support programs to develop treatment results for these [....] » Read More

Emmanuel Ifeanyi Obeagu, Speaker at Hematology Conferences
Oral Presentation
Emmanuel Ifeanyi Obeagu, Kampala International University, Uganda

In pregnancy, anaemia is when haemoglobin concentration is less than 11 g/dL in the first and the third trimester or a haemoglobin concentration of less than 10.5 g/dL in the second trimester. Globally, anaemia is a public health problem since ancient years. During pregnancy, era [....] » Read More

Brandon Lucke Wold, Speaker at Hematology Meetings
Oral Presentation
Brandon Lucke Wold, University of Florida, United States

Background: Curvularia is a ubiquitous fungus found in tropical climates and has been reported to grow on marijuana leaves. Rarely, it can infect humans and propagate from the nasal sinuses into the brain. Case: A 28-year-old immunocompetent patient presented with history of nas [....] » Read More

Noha Hassan Mahboub, Speaker at Hematology Meetings
Oral Presentation
Noha Hassan Mahboub, October 6 University, Cairo University, Egypt

Sickle Cell Anemia is an increasing global health genetic problem characterized by chronic hemolytic anemia and tissue damage due to repeated microvascular obstruction by sickle shaped cells. Estimations suggest increasing number of infants born with Sickle Cell Anemia by year [....] » Read More

Ahmed N Ghanem, Speaker at Hematology Conferences
Oral Presentation
Ahmed N Ghanem, Mansoura University, Egypt

Volume kinetic (VK) shocks are cardiovascular shocks induced by acute substantial volume changes of the cardiovascular system in either direction by decrease or increase. A decrease in cardiovascular volume induces the long established and well-known hypovolemic and haemorrhagic [....] » Read More

Sanghoon Lee, Speaker at Blood Diseases Congress
Oral Presentation
Sanghoon Lee, Marshall University, United States

Cancers have long been investigated to be uncovered by differential microenvironmental conditions of malignant tumors for effective cancer diagnosis, prevention, and treatment. Recent advances in whole slide imaging technologies with ultra-high resolution have led to the accurate [....] » Read More

Rishabh Charan Choudhary, Speaker at Hematology Conferences
Oral Presentation
Rishabh Charan Choudhary, Feinstein Institutes for Medical Research, United States

Vagus nerve stimulation (VNS) is a Food and Drug Administration (FDA) approved technique in epilepsy and depression. VNS is usually performed by providing electrical stimulation to the vagus nerve in the neck region by placing an electrode. Along with the electrical stimulation, [....] » Read More

Salako Abideen Olurotimi, Speaker at Blood Disorders Conference
Oral Presentation
Salako Abideen Olurotimi, Nigerian Institute of Medical Research, Nigeria

Background:Myocardial Ischaemia (MI) in children living with sickle cell anaemia (SCA) is rarely reported, especially in low- and middle-income countries like Nigeria. The occurrence of MI among children living with this disease could portend untoward outcomes on their quality of [....] » Read More

Mousa Qatawneh, Speaker at Hematology Conferences
Oral Presentation
Mousa Qatawneh, Queen Rania Children's Hospital, Jordan

Diagnosis and treatment of inherited bleeding disorders in children secondary to deficiency in single or multiple coagulation factor is of great importance and represent a challenging issue in developing country like Jordan. The prevalence of bleeding disorders varies in differen [....] » Read More

Samiah Shahid, Speaker at Hematology Conferences
Oral Presentation
Samiah Shahid, The University of Lahore, Pakistan

Thalassemia is a hereditary disease due to defective globin chain production. This defective globin become the cause of accumulation of excessive globin (unbound) in the erythrocytes and ultimately lead to the ineffective erythropoiesis. Despite the modern technologies, there is [....] » Read More

Ahmed Kamel Abdulhamid, Speaker at Blood Disorders Conference
Oral Presentation
Ahmed Kamel Abdulhamid, University of Kerbala, Iraq

Background and aim: Benign prostatic Hypertrophy or hyperplasia (BPH) is a frequent urological complain particularly in old age individuals. Those patients usually have other risk factors (such as ischemic cardiovascular diseases) for which they might be treated with anti-thrombo [....] » Read More

Shubham Rastogi, Speaker at Hematology Conferences
Oral Presentation
Shubham Rastogi, Horiba Medical, France

This study evaluated and compared the overall equipment effectiveness (OEE), sensitivity, specificity, and efficiency of the high-end haematology analyzers to enhance the mid to high laboratory’s productivity and Efficiency. Audience Takeaway: By adding to their pr [....] » Read More

Thoraya Mohamed Abdel Hamid, Speaker at Hematology Conferences
Oral Presentation
Thoraya Mohamed Abdel Hamid, NCI Cairo University, Egypt

Aim: This retrospective study aimed to evaluate the efficacy and safety of adopting the pediatric-inspired ALL chemotherapy protocol in treating AYA patients diagnosed with ALL and to compare the clinical outcome with other adult ALL chemotherapy Protocol. Methods: T [....] » Read More

Shaoying Li, Speaker at Hematology Conferences
Oral Presentation
Shaoying Li, MD Anderson, United States

High grade B-cell lymphoma with MYC and BCL2 with or without BCL6 rearrangements is also called double/triple hit lymphoma (DHL). MYC and BCL6 rearrangements, the previous MYC and BCL6 DHL has been excluded from this category in the 5th WHO classification. In the past few years, [....] » Read More

J Somasekar, Speaker at Hematology Conferences
Oral Presentation
J Somasekar, Gopalan College of Engineering and Management, India

Anemia is a common blood disorder that affects an estimated 1.62 billion people worldwide, which is approximately 24.8% of the global population. Women and children are particularly vulnerable to anemia, with an estimated 29% of non-pregnant women, 38% of pregnant women, and 47% [....] » Read More

Mwesigwa Charles, Speaker at Hematology Conferences
Oral Presentation
Mwesigwa Charles, Practical Haematology, Uganda

Today, practical haematology is a one medical piece of science which is basically here to gives an opening eye  on the origins of several cancers like we very well understand it that cancerous causes are mostly issues to do with the several mutagens which in actual situation [....] » Read More

Anupriya Ganguly, Speaker at Blood Disorders Events
Poster Presentation
Anupriya Ganguly, University of Florida- Jacksonville, United States

Introduction: While new approaches in treatment have improved diagnosis and management of sickle cell disease (SCD) over the last few decades, many patients still have severe complications leading to repeat ED visits and hospitalizations. Better risk stratification can help to re [....] » Read More

Mehndi Dandwani, Speaker at #HematologyConferences
Poster Presentation
Mehndi Dandwani, Danbury Hospital, United States

Coronavirus disease 2019 (COVID-19) has shown high incidences of thrombosIs, especially pulmonary embolism. Superior Vena Cava Syndrome (SVCS) can be caused by external compression by tumors or intrinsic thrombosis. Here, we report a rare case of SVC thrombosis with a history of [....] » Read More

Madeeha Subhan Waleed, Speaker at Blood Disorder conference
Poster Presentation
Madeeha Subhan Waleed, Lower Bucks Hospital, United States

Moya moya disease is a chronic cerebral vasculopathy first described in 1957. The disease is named after the appearance of collateral blood vessels that form following the gradual occlusion of arteries of the circle of Willis. The term Moya moya disease (MMD) is used for the dise [....] » Read More

Marie M Plante , Speaker at Hematology Conferences
Poster Presentation
Marie M Plante , Mayo Clinic Florida, United States

Hyperviscosity syndrome (HVS) is an emergent complication of Waldenstrom’s Macroglobulinemia (WM) characterized by neurological, visual, and auditory impairment. Only few cases of HVS with bilateral visual and auditory impairment have been reported in the literature. We rep [....] » Read More

Madeeha Subhan Waleed, Speaker at Blood Disorder conference
Poster Presentation
Madeeha Subhan Waleed, Lower Bucks Hospital, United States

Introduction:Coronavirus disease 2019 also known as COVID-19 is caused by SARS-CoV-2 virus. The disease's symptoms range from asymptomatic to inflammatory cytokine form involving multiple organs. Hematological complications of COVID-19 include cytopenia, coagulation abnormali [....] » Read More

Yao Liu, Speaker at Hematology Conferences
Poster Presentation
Yao Liu, Chongqing University Cancer Hospital, China

Background: HIV-associated lymphoma is the most common subtype of HIV-associated cancers, with a very low incidence. To date, there are only few retrospective studies analyzing the clinical features and prognosis of HIV-associated lymphoma. Therefore, we performed a study to anal [....] » Read More

Annie Rose A Ammar, Speaker at Blood Diseases Congress
Poster Presentation
Annie Rose A Ammar, Zamboanga City Medical Center, Philippines

Rationale and objectives: Iron Deficiency Anemia (IDA) is the most common cause of anemia worldwide but despite that, it is still commonly missed by many physicians. This paper will present a rare case of three siblings with iron refractory iron deficiency anemia (IRIDA) who were [....] » Read More

Esraa Elsayed Abass, Speaker at Hematology Conferences
Poster Presentation
Esraa Elsayed Abass, October 6 University, Cairo University, Egypt

Back ground: Functional capacity is an individual’s ability to perform daily activities related to the participation in the community. Beta-thalassemia is a blood disorder characterized by decreased production of hemoglobin which may in turn results in anemia in earl [....] » Read More

Mona S El Ashry, Speaker at Hematology Meetings
Poster Presentation
Mona S El Ashry, Cairo University, Egypt

Background: Acute Myeloid Leukemia (AML) is a complicated disease characterized by the uncontrolled proliferation of hematopoietic precursors caused by various genetic alterations. Objective: This prospective study aimed at the characterization of RUNX1 gene rearrangements and [....] » Read More

Rim Frikha, Speaker at Hematology Conferences
Poster Presentation
Rim Frikha, Department of Medical Genetics-University Hospital of Sfax, Tunisia

Background: Acute lymphoblastic leukaemia (ALL) is a heterogeneous disease that is often associated with several chromosomal and molecular abnormalities. Patients who have the Philadelphia (Ph) chromosome and associated BCR-ABL1 oncogene have a particularly poor prognosis. Philad [....] » Read More

Francis Torres, Speaker at Hematology Conferences
Poster Presentation
Francis Torres, Children's Hospital of San Antonio, United States

Introduction/background: Any discrepancies of Factor VII (FVII) activity levels using different thromboplastin in a prolonged Prothrombin Time (PT), suspect FVII Padua. This case presented with PT discrepancies using different thromboplastins, FVII Padua is highly suspected. [....] » Read More

Danish Safi, Speaker at Hematology Conferences
Oral Presentation
Danish Safi, West Virginia University, United States

Introduction:Herein we demonstrate anticoagulation therapy (AT) effects and provide reporting of lupus anticoagulant evaluations using HemosIL® reagents. Anticoagulation therapies are known to interfere with lupus anticoagulant (LAC) testing but have not been investigated usi [....] » Read More

Tran Der Tan, Speaker at Blood Diseases Congress
Oral Presentation
Tran Der Tan, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan

Background:The present standard treatment for fit newly diagnosed acute myeloid leukemia patients is idarubicin or daunorubicin plus cytarabine (3 + 7 regimen), followed by allogeneic hematopoietic stem cell transplantation. The complete remission rate after induction therapy is [....] » Read More

Faten Hassan Abdelazeim, Speaker at Blood Diseases Congress
Oral Presentation
Faten Hassan Abdelazeim, October 6 University, Egypt

Sickle Cell Anemia is an increasing global health genetic problem characterized by chronic hemolytic anemia and tissue damage due to repeated microvascular obstruction by sickle shaped cells. Estimations suggest increasing number of infants born with Sickle Cell Anemia by year 20 [....] » Read More

Faten Hassan Abdelazeim, Speaker at Blood Diseases Congress
Oral Presentation
Faten Hassan Abdelazeim, October 6 University, Egypt

Back ground: Functional capacity is an individual’s ability to perform daily activities related to the participation in the community. Beta-thalassemia is a blood disorder characterized by decreased production of hemoglobin which may in turn results in anemia in early [....] » Read More

Hamed Bazrafshan, Speaker at Hematology Meetings
Oral Presentation
Hamed Bazrafshan, Shiraz University of Medical Sciences, Iran (Islamic Republic of)

Background: SYNTAX score is one of the risk assessment systems to predict cardiac events in acute coronary syndrome patients. Despite the large number of SYNTAX score benefits, invasive methods such as coronary angiography are necessary to perform the scoring. We hypothesized tha [....] » Read More

Lilija Bancevica, Speaker at Hematology Conferences
Oral Presentation
Lilija Bancevica, Riga Stradins University, Latvia

Introduction: Mantle cell lymphoma is a rare subtype of non-Hodgkin’s lymphoma, which may develop into other subtypes, such as diffuse large B-cell lymphoma, which is the most common among all non-Hodgkin's lymphomas. Usual clinical features of diffuse large B-cell [....] » Read More

Lucia Mundo, Speaker at Hematology Conferences
Oral Presentation
Lucia Mundo, University of Limerick, Italy

Burkitt lymphoma (BL), which arise from germinal centre B cells (GCB), is an aggressive non Hodgkin B-cell lymphoma. The hallmark of nearly all BL tumours is the chromosomal translocation between the MYC gene and one of the immunoglobulins (Ig) heavy or light chain loci. In accor [....] » Read More

Watsapp